Four-year follow-up of endoscopic gastroplication for the treatment of gastroesophageal reflux disease

Table 1 Baseline patient characteristics¹n (%)

Characteristic	Study group (n = 50)
Age (yr)	46 (11)
Male sex	64
Body mass index (kg/m2)	27 (4)
GERD symptom score2
Heartburn	18 (15-20)
Regurgitation	15 (12-18)
SF-20 score3
Physical function	50 (17-75)
Role function	100 (0-100)
Social function	80 (60-100)
Mental health	76 (60-88)
General health	40 (18-70)
Bodily pain perception	75 (50-75)
PPI dose (mg)4	40 (38-54)
Time pH < 4, %	8.4 (6.1-12.7)
LES pressure (kPa)	0.9 (0.3-1.5)
Hiatal hernia length (cm)	1 (1-2)
Esophagitis grade A/B with or without Barrett’s metaplasia, n (%)	38

¹Data are presented for all patients included in the analyses, values enclosed in parentheses are means (SD) or medians (IQR);

²Frequency multiplied with severity; Scores range from 0 to 24 and were scored while off antisecretory drugs;

³Short-Form General Health Survey scores range from 0 to 100, with higher scores indicating better function, except for the bodily pain perception score;

⁴Proton pump inhibitor dose per day. GERD: Gastroesophageal reflux disease; PPI: Proton pump inhibitor; LES: Lower esophageal sphincter.